Pear Therapeutics to Participate in the 2019 HLTH Conference

10:49 EDT 21 Oct 2019 | Businesswire
This article has expired, however you can still download the PDF.
Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced that Corey McCann M.D., Ph.D., President and CEO, will participate in two panel discussions on addiction and digital therapeutics at the 2019 HLTH Conference ...

Other Sources for this Article

Matt Gold
+1 212-373-6051


More From BioPortfolio on "Pear Therapeutics to Participate in the 2019 HLTH Conference"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...